A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
Authors
Keywords
Amyloid Precursor Protein, Endogenous Peptide, Peptidomic Analysis, Drug Treatment Effect, Golgi Apparatus Protein
Journal
Alzheimers Research & Therapy
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-25
DOI
10.1186/s13195-016-0178-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
- (2015) Sandrine Andrieu et al. LANCET NEUROLOGY
- An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
- (2014) Mikko Hölttä et al. JOURNAL OF PROTEOME RESEARCH
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination
- (2014) Juan A Vizcaíno et al. NATURE BIOTECHNOLOGY
- Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
- (2013) Kaj Blennow et al. NEUROPSYCHOPHARMACOLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
- (2013) C. L. Masters et al. Cold Spring Harbor Perspectives in Medicine
- Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?
- (2012) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment
- (2012) Erik Portelius et al. CURRENT PHARMACEUTICAL DESIGN
- Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
- (2012) Mikko Hölttä et al. PLoS One
- Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
- (2011) Holger Jahn et al. PLoS One
- A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
- (2010) Erik Portelius et al. Alzheimers Research & Therapy
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- The 28-amino acid form of an APLP1-derived Aβ-like peptide is a surrogate marker for Aβ42 production in the central nervous system
- (2009) Kanta Yanagida et al. EMBO Molecular Medicine
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- A novel pathway for amyloid precursor protein processing
- (2009) Erik Portelius et al. NEUROBIOLOGY OF AGING
- Relative Quantification of Proteins in Human Cerebrospinal Fluids by MS/MS Using 6-Plex Isobaric Tags
- (2008) Loïc Dayon et al. ANALYTICAL CHEMISTRY
- Integrated Analysis of the Cerebrospinal Fluid Peptidome and Proteome
- (2007) Alexandre Zougman et al. JOURNAL OF PROTEOME RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started